Research advances therapy to protect against dengue virus
MIT team presents a novel approach to developing a treatment using mutated antibodies.
MIT team presents a novel approach to developing a treatment using mutated antibodies.
Drugs that block nitric oxide could weaken cancer cells’ resistance, researchers say.
Measuring enzyme levels in patients may reveal healthy cells’ ability to survive chemotherapy.
MIT class offers student teams a chance to create business ventures based on neurotechnology research.
Ragon Institute researchers develop a method to identify weak points in viral proteins that could be exploited for vaccine development.
Griffith, Miller, Schulz and Teng awarded the Institute’s highest undergraduate teaching honor.
Ed Boyden honored for his work on optogenetics; will share 1 million Euro prize with five other researchers.
Automated system for high-speed analysis of vertebrate larvae could aid drug development.
MIT engineers design new synthetic biology circuits that combine memory and logic.
Enlisted in the fight against HIV, MIT engineers and scientists contribute new technology, materials and computational studies.
Polymer film that gradually releases DNA coding for viral proteins could offer a better alternative to traditional vaccines.
Scientists track ocean microbe populations in their natural habitat to create a ‘day in the life’ montage.
Mutant forms of the gene disrupt chemical modifications that control access to genes necessary for normal brain cell function.
MIT researchers are designing tools to analyze cells at the microscale.